Novavax (NASDAQ: NVAX) was once a leading contender to dominate the coronavirus vaccine market. The company faced several challenges, however, and although it successfully launched its vaccine, ...

GAITHERSBURG, Md., Aug. 27, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that the U.S. Food and Drug Administration has approved the Nuvaxovid ™ 2025-2026 Formula for the ...

Biotechnology company Novavax, Inc. (NASDAQ: NVAX) announced that NVX-CoV2373, Novavax's recombinant nanoparticle protein-based COVID-19 vaccine with Matrix-M adjuvant, has been granted a second ...

The new COVID-19 vaccine from Novavax is safe and effective. Better yet, it’s easy to ship and store, making it ideal for poorer countries that are still under-vaxxed. The company’s shot, called ...

STATEN ISLAND, N.Y. — The World Health Organization (WHO) issued an emergency use listing (EUL) for another coronavirus (COVID-19) vaccine — Nuvaxovid — it was announced Tuesday. The new vaccine is ...

Authorization could allow Nuvaxovid™ to be used as a booster regardless of previous vaccine history GAITHERSBURG, Md., Sept. 1, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology ...

Five years after the COVID-19 pandemic gripped the world, the U.S. FDA is moving away from annual routine boosters for all children and adults. Instead of that one-size-fits-all regulatory framework ...

On September 12, the European Commission authorized the use of the Nuvaxovid Covid-19 vaccine as both a homologous and heterologous booster for adults 18 years of age and older. (Photo by Patrick van ...

(RTTNews) - Novavax (NVAX) has completed the transfer of the U.S. marketing authorization for its COVID-19 vaccine, Nuvaxovid to Sanofi (SNY), enabling Sanofi to take full responsibility for ...

The World Health Organization issued an emergency use listing (EUL) Tuesday for Nuvaxovid following its assessment and approval earlier by the European Medicines Agency (EMA). The vaccine was ...